Position in NGNE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,862,483
+$5,059,939 QoQ
Shares Held
408,982
+5.7% QoQ
Ownership
2.04%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#13
of 112 holders
Holding Since
Sep 2023
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NGNE Over Time
Shares Held
Position Value (USD)
Derivatives in NGNE
reported options exposure · as of Jun 30, 2026CallValue
$839,715
CallShares
26,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. NGNE ranks #82 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in NGNE
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,862,483 | 408,982 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $839,715 | 26,700 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $7,802,544 | 387,031 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $223,776 | 11,100 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $304,416 | 15,100 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $7,503,096 | 364,228 | Shares | Defined | 2026-02-17 | |
| 2025-03-31 | $117,100 | 10,000 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $192,231 | 16,416 | Shares | Defined | 2025-05-15 | |
| 2025-03-31 | $475,426 | 40,600 | Call | Defined | 2025-05-15 | |
| 2024-12-31 | $713,232 | 31,200 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $880,110 | 38,500 | Put | Defined | 2025-02-14 | |
| 2023-09-30 NLTX | — | 3,560 | Call | Defined | 2023-11-14 | |
| 2023-09-30 NLTX | — | 21,961 | Shares | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||